Heart transplant disparities have improved since the adoption of the Affordable Care Act; if the law is repealed, experts fear these disparities will return.
Compared with age, pulmonary hypertension, right ventricular failure, and cardiopulmonary bypass time may better predict outcomes in heart transplantation.
Patients undergoing empagliflozin therapy experienced a significant reduction in weight and BMI.
The Advanced Training Statement for advanced heart failure and transplant cardiology consists of 6 general competencies.
LVEF increased from 20% to 24% in patients with ischemic cardiomyopathy and from 17% to 27% in patients with nonischemic cardiomyopathy.
Obese patients were at increased risk of death compared with patients of normal weight.
Restrictive Cardiomyopathy, Congenital Heart Disease Patients Have Higher Risks of Death Awaiting Transplantation
Risk of death adjusted hazard ratios by diagnoses relative to dilated cardiomyopathy were 1.70 (restrictive cardiomyopathy), 1.10 (ischemic cardiomyopathy), 1.23 (hypertrophic cardiomyopathy), 1.30 (valvular disease) and 1.37 (congenital heart disease).
For patients with mechanical circulatory support, a transplantation risk score can help predict mortality risk.
Basal-to-apical longitudinal strain abnormalities are similar in several types of cardiac amyloidosis.
Developing 3D technology could help surgeons choose donors for pediatric heart transplants.
The Cardiology Advisor Articles
- The Mounting Evidence Against Electronic Cigarette Use
- Entresto Significantly Improves Physical, Social Activity in Heart Failure Patients
- Oxygen Therapy in Acute MI Not Associated With Clinical Benefit
- Nonpsychotic Cannabinoids in Hypertension: Benefits and Harms
- ACC and AHA Release 2018 Quality Measures for Cardiac Rehabilitation